Background
Methods
Study Population
Design
Variables
Subpopulations
Statistical Analyses
Results
Study population | ||
---|---|---|
Characteristic | Primary sector patients (n = 94) | Secondary sector patients (n = 97) |
Age, mean (min., max.) | 44 (18–76) | 47 (20–85) |
Sex, n (%) | ||
Male | 44 (47) | 45 (46) |
Female | 50 (53) | 52 (54) |
Pain location, n (%) | ||
Low back only* | 70 (75) | 28 (29) |
Leg pain (+/- LBP) | 24 (25) | 69 (71) |
Duration of current problem, n (%) | ||
≤ 30 days | 69 (73) | 12 (12) |
> 30 days | 23 (24) | 79 (81) |
Missing | 2 (2) | 6 (6) |
Use of pain medication†, n (%) | ||
≤ a couple of times a week | 59 (63) | 39 (40) |
> a couple of times a week | 33 (35) | 58 (60) |
Missing | 2 (2) | - |
Disability at baseline 0–100 scale, mean (SD) | ||
ODI | 27.4 (16.2) | 33.7 (14.5) ‡ |
RMQ | 40.3 (18.5) | 45.2 (16.3) |
LBPRSdisability
| 33.6 (17.8) | 45.2 (17.8) ‡ |
SF36 (pf) | 34.9 (25.0) | 45.7 (20.3) ‡ |
Pain at baseline, 0–100 scale (mean, SD) | ||
LBPRSpain
| 37.4 (21.1) | 47.7 (22.5) ‡ |
SF36 (bp) | 64.9 (20.2) | 64.0 (20.5) |
NRSpain over the past week | 43.3 (23.2) | 48.6 (25.3) |
Distribution-based responsiveness
Instrument | Primary Sector Patients | Secondary Sector Patients | ||||
---|---|---|---|---|---|---|
n | Mean raw change (SD) | SRMraw (95% CI) | n | Mean raw change (SD) | SRMraw (95% CI) | |
LBP only
| ||||||
ODI | 69 | 18.5 (16.8) | 1.1 (0,8; 1,4) | 28 | 3.0 (11.7) | 0.3 (-0,1; 0,6) |
RMQ | 69 | 27.7 (19.4) | 1.4* (1,2; 1,7) | 28 | 7.5 (15.7) | 0.5 (0,2; 0,8) |
LBPRSdisability
| 67 | 15.4 (22.5) | 0.7 (0,3; 1,0) | 28 | 2.7 (18.6) | 0.1 (-0,2; 0,5) |
SF36 (pf) | 70 | 23.6 (24.4) | 1.0 (0,8; 1,2) | 28 | 5.6 (16.9) | 0.3 (0,0; 0,7) |
LBPRSpain
| 68 | 18.7 (20.8) | 0.9 (0,5; 1,3) | 27 | 2.1 (16.1) | 0.1 (-0,3; 0,5) |
SF36 (bp) | 70 | 40.2 (28.6) | 1.4* (1,0; 1,8) | 28 | 10.8 (17.1) | 0.6* (0,2; 1,0) |
NRSpain
| 69 | 26.2 (23.4) | 1.1 (0,8; 1,5) | 26 | 1.4 (18.1) | 0.1 (-0,3; 0,5) |
Leg pain (+/- LBP)
| ||||||
ODI | 24 | 12.0 (13.5) | 0.9 (0,5; 1,2) | 69 | 3.5 (9.5) | 0.4 (0,1; 0,6) |
RMQ | 24 | 18.8 (22.0) | 0.9 (0,5; 1,2) | 68 | 3.6 (12.1) | 0.3 (0,1; 0,5) |
LBPRSdisability
| 24 | 10.8 (17.9) | 0.6 (0,2; 1,0) | 69 | 4.5 (10.6) | 0.4 (0,2; 0,7) |
SF36 (pf) | 24 | 15.5 (24.0) | 0.6 (0,3; 1,0) | 69 | 5.1 (15.4) | 0.3 (0,1; 0,6) |
LBPRSpain
| 24 | 23.5 (25.7) | 0.9 (0,5; 1,3) | 66 | 7.8 (15.7) | 0.5 (0,2; 0,8) |
SF36 (bp) | 24 | 28.4 (26.4) | 1.1 (0,6; 1,5) | 69 | 12.3 (18.0) | 0.7* (0,4; 1,0) |
NRSpain
| 23 | 25.7 (30.4) | 0.8 (0,4; 1,2) | 65 | 7.8 (22.7) | 0.3 (0,1; 0,6) |
Raw change scores (0–100 scale) | Original scale change score | ||||||
---|---|---|---|---|---|---|---|
ODI | RMQ | LBPRSdisability
| SF36 (pf) | LBPRSpain
| SF36 (bp)* | NRSpain
| |
10 | 10 | 2.3 | 3 | 2 | 6 | 1 | 1 |
20 | 20 | 4.6 | 6 | 4 | 12 | 2 | 2 |
30 | 30 | 6.9 | 9 | 6 | 18 | 3 | 3 |
40 | 40 | 9.2 | 12 | 8 | 24 | 4 | 4 |
50 | 50 | 11.5 | 15 | 10 | 30 | 5 | 5 |
60 | 60 | 13.8 | 18 | 12 | 36 | 6 | 6 |
70 | 70 | 16.1 | 21 | 14 | 42 | 7 | 7 |
80 | 80 | 18.4 | 24 | 16 | 48 | 8 | 8 |
90 | 90 | 20.7 | 27 | 18 | 54 | 9 | 9 |
100 | 100 | 23.0 | 30 | 20 | 60 | 10 | 10 |
Anchor-based responsiveness
Important improvement vs. no change
Instrument | Important improvement | No change | Difference |
P
| ||
---|---|---|---|---|---|---|
n | SRMraw (95% CI) | n | SRMraw (95% CI) | |||
Subpopulations
| ||||||
Primary Sector Patients
| ||||||
ODI | 63 | 1.4 (1.2; 1.7) | 23 | 0.8 (0.4; 1.2) | 0.6 | 0.05 |
RMQ | 63 | 1.7 (1.4; 2.0) | 23 | 0.7 (0.3; 1.1) | 1.0 | |
LBPRSdisability
| 62 | 0.8 (0.4; 1.2) | 22 | 0.5 (0.1; 0.9) | 0.3 | |
SF36 (pf) | 64 | 1.1 (0.9; 1.3) | 23 | 0.4 (0.0; 0.8) | 0.7 | |
LPBRSpain
| 62 | 1.4 (1.1; 1.6) | 23 | 0.6 (0.1; 1.1) | 0.8 | 0.08 |
SF36 (bp) | 64 | 2.1 (1.6; 2.5) | 23 | 0.8 (0.4; 1.3) | 1.2 | |
NRSpain
| 62 | 1.5 (1.2; 1.8) | 23 | 0.8 (0.3; 1.3) | 0.7 | |
Secondary Sector Patients
| ||||||
ODI | 19 | 1.0 (0.3; 1.7) | 43 | 0.2 (-0.1; 0.5) | 0.8 | 0.01 |
RMQ | 18 | 1.3 (0.7; 1.9) | 43 | 0.3 (0.0; 0.6) | 1.0 | |
LBPRSdisability
| 19 | 0.8 (0.4; 1.3) | 43 | 0.3 (0.0; 0.7) | 0.5 | |
SF36 (pf) | 19 | 0.7 (0.3; 1.1) | 43 | 0.4 (0.1; 0.7) | 0.3 | |
LPBRSpain
| 18 | 1.1 (0.3; 1.8) | 42 | 0.2 (-0.1; 0.5) | 0.9 | 0.06 |
SF36 (bp) | 19 | 2.1 (1.1; 3.0) | 43 | 0.7 (0.3; 1.0) | 1.4 | |
NRSpain
| 18 | 0.9 (0.4; 1.3) | 41 | 0.2 (-0.1; 0.5) | 0.7 | |
LBP only patients
| ||||||
ODI | 58 | 1.4 (1.1; 1.6) | 21 | 0.7 (0.3; 1.1) | 0.7 | 0.03 |
RMQ | 58 | 1.7 (1.4; 2.0) | 21 | 0.7 (0.4; 1.0) | 1.0 | |
LBPRSdisability
| 57 | 0.8 (0.4; 1.3) | 20 | 0.5 (0.2; 0.9) | 0.3 | |
SF36 (pf) | 59 | 1.1 (0.9; 1.3) | 21 | 0.7 (0.3; 1.0) | 0.4 | |
LPBRSpain
| 57 | 1.3 (1.0; 1.6) | 21 | 0.5 (0.0; 1.0) | 0.8 | 0.07 |
SF36 (bp) | 59 | 1.9 (1.5; 2.3) | 21 | 0.9 (0.4; 1.4) | 1.2 | |
NRSpain
| 58 | 1.4 (1.1; 1.7) | 21 | 0.7 (0.3; 1.1) | 0.7 | |
Leg pain (+/- LBP)
| ||||||
ODI | 24 | 1.2 (0.6; 1.7) | 45 | 0.3 (0.0; 0.6) | 0.9 | 0.05 |
RMQ | 23 | 1.3 (0.8; 1.7) | 45 | 0.3 (0.0; 0.6) | 1.0 | |
LBPRSdisability
| 24 | 0.8 (0.3; 1.2) | 45 | 0.3 (0.0; 0.7) | 0.5 | |
SF36 (pf) | 24 | 0.8 (0.4; 1.2) | 45 | 0.3 (0.0; 0.6) | 0.5 | |
LPBRSpain
| 23 | 1.3 (0.7; 1.9) | 44 | 0.3 (0.0; 0.6) | 1.0 | 0.46 |
SF36 (bp) | 24 | 2.0 (1.3; 2.6) | 45 | 0.6 (0.3; 1.0) | 1.1 | |
NRSpain
| 22 | 1.3 (0.8; 1.8) | 43 | 0.2 (-0.1; 0.5) | 1.1 |
Area under the ROC curve
Minimal Clinically Important Difference
Instrument | Overall MCID | Quarter-specific MCIDs by baseline entry score§ | |||
---|---|---|---|---|---|
0–25 | 26–50 | 51–75 | 76–100 | ||
All patients
| |||||
ODI | 11† (11) ‡ | 8† (8) ‡ | 12† (12) ‡ | 40† (40)‡ | |
RMQ | 5 (20) | 2 (7) | 5 (20) | 6 (27) | - |
LBPRSdisability
| 5 (17) | 1 (3) | 4 (13) | 10 (33) | - |
SF36 (pf) | 3 (17) | 1 (5) | 3 (17) | 7 (33) | - |
LBPRSpain
| 6 (10) | 4 (7) | 10 (17) | 23 (38) | 11† (18) ‡ |
SF36 (bp) | 3 (29) | - | 2 (22) | 3 (33) | 5 (50) |
NRSpain
| 1 (10) | 1 (10) | 2 (20) | 4 (40) | 3 (30) |
Subpopulations
| |||||
Primary sector patients
| |||||
ODI | 9 (9) | 9 (9) | 16 (16) | 40 (40) | - |
RMQ | 5 (20) | 2 (7)* | 6 (27) | 11 (47) | - |
LBPRSdisability
| 5 (17) | 0 (0) | 6 (20) | 10 (33) | - |
SF36 (pf) | 2 (11) | 1 (5)* | 2 (10) | 9 (45) | - |
LBPRSpain
| 12 (20) | 6 (10) | 13 (22) | 20 (33) | - |
SF36 (bp) | 4 (42) | - | 4 (38)* | 2 (19) | 5 (50) |
NRSpain
| 4 (40) | 1 (10)* | 3 (30) | 4 (40) | - |
Secondary sector patients
| |||||
ODI | 8 (8) | 1 (1)* | 8 (8) | 18 (18)* | - |
RMQ | 2 (7) | 4 (17) | 2 (7) | 2 (7) | - |
LBPRSdisability
| 5 (17) | 1 (3) | 5 (17) | 3 (10) | - |
SF36 (pf) | 6 (30) | 1 (5) | 2 (10) | 3 (33)* | - |
LBPRSpain
| 8 (13) | 4 (7) | 10 (17) | 17 (28) | - |
SF36 (bp) | 2 (22) | - | 2 (22)* | 3 (33) | 3 (30) |
NRSpain
| 2 (20) | 1 (10) | 2 (20) | 4 (40) | 1 (10) |
LBP only patients
| |||||
ODI | 9 (9) | 9 (9) | 13 (13)* | 40 (40) | - |
RMQ | 2 (7) | 2 (7) | 5 (23) | 11 (47) | - |
LBPRSdisability
| 5 (17) | 1 (3) | 6 (20) | 13 (43) | - |
SF36 (pf) | 1 (5) | 1 (5) | 3 (17) | 9 (45) | - |
LBPRSpain
| 7 (12) | 7 (12) | 13 (22) | 25 (42) | - |
SF36 (bp) | 4 (43) | - | 1 (10)* | 3 (33) | 5 (50) |
NRSpain
| 1 (10) | 1 (10) | 3 (30)* | 4 (40) | 5 (50)* |
Leg pain (+/- LBP)
| |||||
ODI | 8 (8) | 3 (3) | 8 (8) | 18 (18) | - |
RMQ | 5 (20) | 0 (0) | 5 (20) | 5 (20) | - |
LBPRSdisability
| 5 (17) | 2 (7)* | 4 (13) | 5 (17) | - |
SF36 (pf) | 4 (20) | 1 (6)* | 2 (10) | 7 (33) | - |
LBPRSpain
| 10 (17) | 6 (10) | 5 (17) | 22 (38) | 11 (18) |
SF36 (bp) | 3 (30) | - | 1 (11) | 2 (19) | 3 (30) |
NRSpain
| 2 (20) | 0 (0) | 2 (20) | 4 (40) | 3 (30) |